Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 15, Number 7—July 2009

Letter

Immunoglobulin G in Ebola Outbreak Survivors, Gabon

Nadia Wauquier1, Pierre Becquart1, Clélia Gasquet, and Eric M. LeroyComments to Author 
Author affiliations: Centre International de Recherches Médicales de Franceville, Franceville, Gabon (N. Wauquier, P Becquart, C Gasquet); Institut de Recherche pour le Développement UMR190, Marseille, France (P. Becquart, C. Gasquet, E.M. Leroy)

Main Article

Table

Adjusted OD values in patients infected with Zaire ebolavirus during 3 outbreaks in Gabon, determined by testing at days 5, 10, and/or 30 after symptom onset and again in 2007 (7 or 11 years after recovery)*

Patient no. Outbreak location and year Adjusted OD at 1:1,600 dilution
Day 5 Day 10 Day 30 2007
1 Mayibout 1996 0.05 1.50 2.52 1.41
2 Mayibout 1996 0.44 0.58 1.14 0.30
3 Mayibout 1996 0.22 1.90 3.17
4 Mayibout 1996 2.09
5 Mayibout 1996 2.31 0.65
6 Mayibout 1996 1.11 3.46
7 Booué 1996 2.64 0.71
8 Booué 1996 1.56 0.49
9 Booué 1996 1.26 1.55 0.31
10 Mekambo 2001 2.60
11 Mekambo 2001 1.90 1.46
12 Mekambo 2001 2.05 0.84
13 Mekambo 2001 0.80 2.13
14 Mekambo 2001 1.84
15 Mekambo 2001 0.71
16 Mekambo 2001 2.77
17 Mekambo 2001 0.10 3.50
18 Mekambo 2001 0.46 1.33
19 Mekambo 2001 0.03 2.50
20 Mekambo 2001 2.90 0.99

*Blank cells indicate data are missing or testing was not performed. OD, optical density.

Main Article

1These authors contributed equally to this article.

Top of Page

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO